NCT06445257View on ClinicalTrials.gov

A Clinical Study Evaluating the Safety and Efficacy of ZRMT Regimen in the Treatment of PCNSL

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

April 13, 2026

Study Completion Date

April 30, 2026

Conditions
Primary Central Nervous System Lymphoma
Interventions
DRUG

zanubrutinib 160 mg BID orally

The ZRMT induction and maintenance regimen

Trial Locations (1)

210000

RECRUITING

The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University（Huai'an First People's Hospital）, Huai'an

All Listed Sponsors
collaborator

Affiliated Hospital of Nantong University

OTHER

collaborator

The First People's Hospital of Changzhou

OTHER

collaborator

The Affiliated Hospital of Xuzhou Medical University

OTHER

collaborator

Northern Jiangsu People's Hospital

OTHER

lead

Huai'an First People's Hospital

OTHER